标题
EC145: a novel targeted agent for adenocarcinoma of the lung
作者
关键词
-
出版物
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 21, Issue 5, Pages 755-761
出版商
Informa Healthcare
发表日期
2012-03-30
DOI
10.1517/13543784.2012.671294
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- PRECEDENT: A randomized phase II trial comparing EC145 and pegylated liposomal doxorubicin (PLD) in combination, versus PLD alone, in subjects with platinum-resistant ovarian cancer.
- (2017) R. W. Naumann et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase I study of the folate-targeted conjugate EC0489 in patients with refractory or advanced metastatic cancer.
- (2017) W. A. Harb et al. JOURNAL OF CLINICAL ONCOLOGY
- PRECEDENT: A randomized phase II trial comparing EC145 and pegylated liposomal doxorubicin (PLD) in combination, versus PLD alone, in subjects with platinum-resistant ovarian cancer.
- (2017) R. W. Naumann et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis
- (2011) Alice T Shaw et al. LANCET ONCOLOGY
- High-dose cyclophosphamide–irinotecan–vincristine for primary refractory neuroblastoma
- (2010) Brian H. Kushner et al. EUROPEAN JOURNAL OF CANCER
- Outcomes of Children With Favorable Histology Wilms Tumor and Peritoneal Implants Treated in National Wilms Tumor Studies-4 and -5
- (2010) John A. Kalapurakal et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Folate-targeted therapeutic and imaging agents for cancer
- (2009) Philip Stewart Low et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Clinical Pharmacokinetics and Exposure-Toxicity Relationship of a Folate-VincaAlkaloid Conjugate EC145 in Cancer Patients
- (2009) Jing Li et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Intracellular Signaling Molecules
- (2009) Edward B. Garon et al. Journal of Thoracic Oncology
- Recent Trends in Targeted Anticancer Prodrug and Conjugate Design
- (2008) Yashveer Singh et al. CURRENT MEDICINAL CHEMISTRY
- Targeted drug delivery via folate receptors
- (2008) Xiaobin Zhao et al. Expert Opinion on Drug Delivery
- Eicosanoid Modulation in Advanced Lung Cancer: Cyclooxygenase-2 Expression Is a Positive Predictive Factor for Celecoxib + Chemotherapy—Cancer and Leukemia Group B Trial 30203
- (2008) Martin J. Edelman et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
- (2008) Giorgio Vittorio Scagliotti et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation